Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
21 - 30 out of 256Page size: 10
  1. 2021
  2. Published

    Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial

    Højsgaard Chow, H., Talbot, J., Lundell, H., Gøbel Madsen, C., Marstrand, L., Lange, Theis, Mahler, M. R., Buhelt, S., Hansen, Rikke Holm, Blinkenberg, M., Romme Christensen, J., Sørensen, Per Soelberg, von Essen, Marina Rode, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2021, In: Neurology(R) neuroimmunology & neuroinflammation. 8, 5, p. 1-10

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network

    Iaffaldano, P., Lucisano, G., Butzkueven, H., Hillert, J., Hyde, R., Koch-Henriksen, N., Magyari, M., Pellegrini, F., Spelman, T., Sørensen, Per Soelberg, Vukusic, S. & Trojano, M., 2021, In: Multiple Sclerosis Journal. 27, 10, p. 1543-1555 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Editorial: Challenges in the diagnosis and treatment of multiple sclerosis

    Sørensen, Per Soelberg, 2021, In: Current Opinion in Neurology. 34, 3, p. 275-276 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  5. Published

    Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Oturai, D. B., Bach Søndergaard, H., Koch-Henriksen, N., Andersen, C., Laursen, J. H., Gustavsen, S., Kristensen, J. T., Magyari, M., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Thørner, L. W., Ullum, H. & Oturai, A. B., 2021, In: Multiple Sclerosis Journal. 27, 2, p. 188-197 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Highly effective disease-modifying treatment as initial MS therapy

    Schmierer, K., Sørensen, Per Soelberg & Baker, D., 2021, In: Current Opinion in Neurology. 34, 3, p. 286-294 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    NAverting multiple sclerosis long-term societal and healthcare costs: The Value of Treatment (VoT) project

    Tinelli, M., Pugliatti, M., Antonovici, A., Hausmann, B., Hellwig, K., Quoidbach, V. & Sørensen, Per Soelberg, 2021, In: Multiple Sclerosis and Related Disorders. 54, 103107.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

    Sharmin, S., Lefort, M., Andersen, J. B., Leray, E., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand’Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C. & 31 others, Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Van der Walt, A., Van Wijmeersch, B., Csepany, T., Spitaleri, D., Vucic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Jensen, Michael Broksgaard, Fredriksen, Jette Lautrup, Bramow, S., Mathiesen, H. K., Schreiber, K. I., Magyari, M. & Danish Multiple Sclerosis Registry, OFSEP and the MSBase investigators, D. M. S. R. O. A. T. M. I., 2021, In: CNS Drugs. 35, p. 1217–1232

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Role of B Cells in Multiple Sclerosis and Related Disorders

    Comi, G., Bar-Or, A., Lassmann, H., Uccelli, A., Hartung, H. P., Montalban, X., Sørensen, Per Soelberg, Hohlfeld, R. & Hauser, S. L., 2021, In: Annals of Neurology. 89, 1, p. 13-23 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

    Uccelli, A., Laroni, A., Ali, R., Battaglia, M. A., Blinkenberg, M., Brundin, L., Clanet, M., Fernandez, O., Marriot, J., Muraro, P., Nabavi, S. M., Oliveri, R. S., Radue, E., Ramo Tello, C., Schiavetti, I., Sellner, J., Sørensen, P. S., Sormani, M. P., Wuerfel, J. T., Freedman, M. S. & 1 others, MESEMS investigators, M. I., 2021, In: The Lancet Neurology. 20, 11, p. 917-929 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey

    Gustavsen, S., Olsson, A., Søndergaard, H. B., Andresen, S. R., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Oturai, A., 2021, In: BMC Neurology. 21, 12 p., 317.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 11025